BCG protects against tuberculosis irrespective of HIV status: a matched case-control study in Mwanza, Tanzania

Publikation: Bidrag til tidsskriftLetterForskningfagfællebedømt

  • Daniel Faurholt-Jepsen
  • Nyagosya Range
  • George PrayGod
  • Kidola Jeremiah
  • Maria Faurholt-Jepsen
  • Martine G Aabye
  • Harleen M S Grewal
  • John Changalucha
  • Daniel R Witte
  • Aase B Andersen
  • Friis, Henrik
While BCG vaccine protects against severe tuberculosis (TB) in children, its effect against adult TB is questionable. Furthermore, it is not known if HIV co-infection modifies the effect of BCG. Among 352 pairs of Tanzanian TB cases and matched controls, the BCG scar was associated with a reduced risk of TB (OR 0.3, 95% CI 0.2 to 0.7, p=0.005), irrespective of HIV status (interaction, p=0.623). BCG vaccination considerably reduced the risk of TB, both among individuals with and without HIV infection.
Udgave nummer3
Sider (fra-til)288-289
Antal sider2
StatusUdgivet - 2013

Bibliografisk note

CURIS 2013 NEXS 044

ID: 44566701